Pneumotox. vs Thoracic Lymph Node Map

Pneumotox®: The drug-induced/iatrogenic respiratory disease website & App. The companion website and App Cardiotox® cover drug-induced cardiotoxicity. By Philippe Camus MD. Professor (emeritus) - Board-certified in pulmonary medicine and cardiology,- Université Bourgone-Europe, Dijon, France. Pneumotox is an aid to the diagnosis and management of respiratory diseases and reactions suspected of being induced by drugs, chemicals, and of iatrogenic origin. Causality assessment and exact diagnosis are the full responsibility of the user. Pneumotox is designed to provide regularly-updated information on drugs causing pulmonary toxicity (>1,700 agents), patterns of involvement (>820) and bibliography (>10,700 as of August 2026) within a few minutes. That may be the crux in emergency situations. Yet, double-checking in and from other sources is indicated. Pneumotox rests on a bibliographic repository built since 1978, which amounts to >50,000 references overall, the vast majority of which is indexed in PubMed. All references were and are carefully reviewed for reliability and causality by the founder, then indexed under the corresponding drug or agent in Pneumotox. Pneumotox can be assessed by causative drug(s), chemicals, herbals, substances of abuse, inhaled incl. e-cigarettes, vaping, inhalants, gases, ionizing radiations (providing the list of patterns), or by patterns of involvement (providing the list of causal drugs/agents). Drug names are generic (International Nonproprietary Names (INN), alphabetical), not brand ones. It may be appropriate to check the exact composition of any proprietary drug, as any other added substance or excipient can be pneumotoxic. Matching generic and brand names which differs with country is the responsibility of the user. Patterns are grouped by families according to the main anatomic site of involvement. If a drug or drug reaction is listed in Pneumotox, that does not equate the patient is demonstrating toxicity. A “Diagnosing DIRD” window in Pneumotox (top panel) may help secure the diagnosis. Lack of case or cases in the literature or in Pneumotox does not exclude a diagnosis of drug toxicity as there may be unpublished cases, you may be seeing the first case ever, or we may have overlooked some information. In such situations, please inform us; Pneumotox cannot be held responsible. Pneumotox can be contacted by mail 7/365 for complementary information, tailored literature, and/or data on rechallenge with the drug. In any patient, particularly the ones with acute respiratory failure, ARDS or acute bronchospasm, exposure to drugs, substances, and/or chemicals must be done exhaustively with the patient, and if needed with the family, health professionals, pharmacy and/or law enforcement personel. And prompt removal of the drug can be lifesaving. Caution: drug withdrawal can produce a flare of the underlying condition for which the drug was exactly given. Deliberate rechallenge can be hazardous as fatal relapse of the respiratiory reaction can supervene. Early sampling of body fluids for drug and/or metabolites is indicated as early as possible, particularly in the severely ill. Knowledge of toxidromes and antidotes capable of countering adverse effects of drugs or chemicals is essential (ex: PMID ). Where in doubt, consider double-checking PubMed, your affiliated Safety for Medicines Department/Agency and the Pharmacovigilance Department of drug companies. They may host more and/or undisclosed information. Patients should be reassured as such incidents are rare oveall. If needed, they are invited to consult with their treating physicians. Monitoring common causal agents (with red digits in stars) for impending toxicity is strongly advised. You may contact Pneumotox anytime through the contact window. ALL RIGHTS RESERVED The current version of Pneumotox website and App were developed by Akyos Communication Dijon France, under the guidance of Philippe Camus MD

Thoracic Lymph Node Map is a clinical decision-support reference that streamlines the evaluation and localization of thoracic lymph node stations on CT. Adapted from the International Association for the Study of Lung Cancer (IASLC) lung cancer project, the app provides a clear, color-coded map of mediastinal, low cervical, and hilar lymph node stations with concise anatomic definitions, N-category information, and sampling options—right at the point of care. Version 4.0 has been rebuilt from the ground up and optimized for iOS 26, featuring a modern, responsive interface designed for radiologists, pulmonologists, oncologists, surgeons, and any health care professional interpreting chest imaging. The app is provided entirely free of charge, with no ads, no subscriptions, and no in-app purchases. --- Key Features IASLC Thoracic Lymph Node Map Integration • Color-coded map adapted from the IASLC lung cancer project • Clear station labels (1–14) with concise anatomic definitions CT-Based Station Overlays • Navigate representative axial CT images of the thorax • Visualize how each lymph node station relates to key mediastinal structures Station Detail Cards • N-category classification (N1/N2/N3) for every station • Common sampling options at a glance • Precise upper, lower, and lateral/anterior/posterior boundaries Common Issues Insights • High-yield clarifications for frequently confused stations • Guidance on distinguishing 4 vs 10, 1 vs 2/3, and more • Aid in aligning CT interpretation with IASLC definitions Enhanced Readability • Support for Dark Mode and Dynamic Type • Clean, distraction-free layout optimized for both iPhone and iPad Offline Access • All data available offline—no login, no network, no server required Requirements • iPhone or iPad running iOS / iPadOS 16.6 or later • Fully optimized for iOS 26 Pricing Thoracic Lymph Node Map is developed and maintained by radiologists. It is provided as a free resource for the medical community, with no advertisements and no subscription required. Medical Disclaimer: This app is for informational purposes only and is not a substitute for professional medical advice. In addition to using this app, always consult a qualified healthcare provider for diagnosis and treatment decisions. Privacy Policy: https://radiologiq.squarespace.com/privacy Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/